Presentation is loading. Please wait.

Presentation is loading. Please wait.

Figure 1. Algorithm for classifying patients with hospital-acquired pneumonia according to the Consensus Statement of the American Thoracic Society. Adapted.

Published byGeorge Quinn Modified over 5 years ago

Similar presentations

Presentation on theme: "Figure 1. Algorithm for classifying patients with hospital-acquired pneumonia according to the Consensus Statement of the American Thoracic Society. Adapted."— Presentation transcript:

1 Figure 1. Algorithm for classifying patients with hospital-acquired pneumonia according to the Consensus Statement of the American Thoracic Society. Adapted with permission of the American Thoracic Society [4]. Copyright © 1996 American Thoracic Society. Hospital-acquired pneumonia in adults: diagnosis, assessment of severity, initial antimicrobial therapy, and preventative strategies. A consensus statement. Am J Respir Crit Care Med 1996; 153:1711–1725. From: Treatment Guidelines and Outcomes of Hospital-Acquired and Ventilator-Associated Pneumonia Clin Infect Dis. 2010;51(Supplement_1):S48-S53. doi: /653049 Clin Infect Dis | © 2010 by the Infectious Diseases Society of America

2 Figure 2. Algorithm for initiating empirical antibiotic therapy for hospital- acquired pneumonia (HAP), ventilator-associated pneumonia (VAP), and health care-associated pneumonia (HCAP), according to the 2005 American Thoracic Society and Infectious Diseases Society of America guideline. *Prior antimicrobial therapy (within 90 days), hospitalization for ⩾5 days, high frequency of antibiotic resistance in the community or the hospital unit, immunosuppressive disease or therapy. Adapted with permission of the American Thoracic Society [5]. Copyright © 2005 American Thoracic Society. Guidelines for the management of adults with hospitalacquired, ventilator-associated, and healthcare-associated Pneumonia.Am J Respir Crit Care Med 2005; 171:388–416. From: Treatment Guidelines and Outcomes of Hospital-Acquired and Ventilator-Associated Pneumonia Clin Infect Dis. 2010;51(Supplement_1):S48-S53. doi: /653049 Clin Infect Dis | © 2010 by the Infectious Diseases Society of America

3 Table 1. Potential Microorganisms in Each Group According to the 1996 Consensus Statement of the American Thoracic Society From: Treatment Guidelines and Outcomes of Hospital-Acquired and Ventilator-Associated Pneumonia Clin Infect Dis. 2010;51(Supplement_1):S48-S53. doi: /653049 Clin Infect Dis | © 2010 by the Infectious Diseases Society of America

4 Table 2. Initial Empirical Antimicrobial Treatment for Patients with Hospital-Acquired, Ventilator-Associated, or Health Care-Associated Pneumonia, according to the 2005 American Thoracic Society and Infectious Disease Society of America Guidelines From: Treatment Guidelines and Outcomes of Hospital-Acquired and Ventilator-Associated Pneumonia Clin Infect Dis. 2010;51(Supplement_1):S48-S53. doi: /653049 Clin Infect Dis | © 2010 by the Infectious Diseases Society of America

5 Table 3. Numbers and Percentages of Microorganisms Responsible for 135 Episodes of Ventilator-Associated Pneumonia Classified According to the Duration of Mechanical Ventilation (MV) and Prior Antibiotic Therapy (ATB) From: Treatment Guidelines and Outcomes of Hospital-Acquired and Ventilator-Associated Pneumonia Clin Infect Dis. 2010;51(Supplement_1):S48-S53. doi: /653049 Clin Infect Dis | © 2010 by the Infectious Diseases Society of America

Download ppt "Figure 1. Algorithm for classifying patients with hospital-acquired pneumonia according to the Consensus Statement of the American Thoracic Society. Adapted."

Similar presentations

Prevention of Ventilator Associated Pneumonia

Prevention of Ventilator Associated Pneumonia
ARE CAP AND HCAP TWO SEPARATE ENTITIES? Francesco Blasi Department Pathophysiology and Transplantation, University of Milan, Italy.

ARE CAP AND HCAP TWO SEPARATE ENTITIES? Francesco Blasi Department Pathophysiology and Transplantation, University of Milan, Italy.
H CAP & H AP Pamela Charity, MD Cathryn Caton, MD, MS.

H CAP & H AP Pamela Charity, MD Cathryn Caton, MD, MS.
TREATMENT OF PNEUMONIA IN ADVANCED DEMENTIA Sophie Allepaerts CHU- Liège Belgium.

TREATMENT OF PNEUMONIA IN ADVANCED DEMENTIA Sophie Allepaerts CHU- Liège Belgium.
Ventilator-Associated Pneumonia. Introduction Definition 48 hours after intubation mechanically ventilated No clinical evidence of pneumonia prior to.

Ventilator-Associated Pneumonia. Introduction Definition 48 hours after intubation mechanically ventilated No clinical evidence of pneumonia prior to.
The Importance of Clinical Oral Care

The Importance of Clinical Oral Care
Enoch Omonge University of Nairobi

Enoch Omonge University of Nairobi
H CAP & H AP Pamela Charity, MD Cathryn Caton, MD, MS.

H CAP & H AP Pamela Charity, MD Cathryn Caton, MD, MS.
Cost-Conscious Care Presentation Follow-up Chest X-Ray in Patients Admitted for Community Acquired Pneumonia Huy Tran, PGY-2 12/12/2013.

Cost-Conscious Care Presentation Follow-up Chest X-Ray in Patients Admitted for Community Acquired Pneumonia Huy Tran, PGY-2 12/12/2013.
Community Acquired Pneumonia (CAP)

Community Acquired Pneumonia (CAP)
Hospital-Acquired Pneumonia

Hospital-Acquired Pneumonia
Community Acquired Pneumonia. Definitions Community acquired pneumonia (CAP) – Infection of the lung parenchyma in a person who is not hospitalized or.

Community Acquired Pneumonia. Definitions Community acquired pneumonia (CAP) – Infection of the lung parenchyma in a person who is not hospitalized or.
HAP and VAP Guidelines Update

HAP and VAP Guidelines Update
Table 3 Clinical response success rate, according to prior effective antimicrobial therapy in hospitalized patients with community-acquired pneumonia given.

Table 3 Clinical response success rate, according to prior effective antimicrobial therapy in hospitalized patients with community-acquired pneumonia given.
Table 4 Risk factors for acquisition of vancomycin-resistant enterococcal (VRE) colonization after transplantation for 120 liver transplant recipients.

Table 4 Risk factors for acquisition of vancomycin-resistant enterococcal (VRE) colonization after transplantation for 120 liver transplant recipients.
Figure 1. Rate of antimicrobial resistance in S. pneumoniae

Figure 1. Rate of antimicrobial resistance in S. pneumoniae
Evaluation of susceptibility patterns of Pseudomonas aeruginosa in respiratory vs. non-respiratory infections and implications for empiric treatment Stephanie.

Evaluation of susceptibility patterns of Pseudomonas aeruginosa in respiratory vs. non-respiratory infections and implications for empiric treatment Stephanie.
Table 5 Characteristics of 12 patients who had 1 test of stool samples that yielded positive results in the prospective clinical assessment for investigation.

Table 5 Characteristics of 12 patients who had 1 test of stool samples that yielded positive results in the prospective clinical assessment for investigation.
Clinical Microbiology and Infection

Clinical Microbiology and Infection
Table 6 The results of virus isolation tests before and after oseltamivir therapy. From: A Comparison of the Effectiveness of Oseltamivir for the Treatment.

Table 6 The results of virus isolation tests before and after oseltamivir therapy. From: A Comparison of the Effectiveness of Oseltamivir for the Treatment.

Similar presentations

Ads by Google